Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCCC 1612: p53 and cf-HPV-DNA in HPV-associated OPSCC
NCT03077243Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Dec 2016
- Primary completion
- Dec 2022
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in oropharyngeal squamous cell carcinoma (OPSCC), sponsored by UNC Lineberger Comprehensive Cancer Center. Started Dec 2016; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
oropharyngeal squamous cell carcinoma (OPSCC)
Beyond the preview
Go deeper on NCT03077243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03077243.